USG Programs

On Thursday, April 25, the Kaiser Family Foundation and the CSIS Global Health Policy Center held a policy roundtable on the latest data on funding for global health, including from the U.S. government. It began with a brief presentation by Joseph Dieleman of the Institute for Health Metrics and Evaluation…

The first comprehensive summary of donor funding for the response to the Ebola outbreak in the Democratic Republic of Congo estimates that at least $546 million was provided by donors from August 2018, when the outbreak started, through September 2019.

This data note provides an accounting of publicly-available information on donor funding to date for the global coronavirus (COVID-19) response.

This data note assesses where the U.S. government has existing global health assets that could be mobilized when and if needed to assist in the COVID-19 response in low and middle income countries.

This brief examines abortion laws in countries that received certain U.S. foreign assistance to better understand the implications of the Helms Amendment (which prohibits the use of foreign assistance to pay for the performance of abortion as a method of family planning or to motivate or coerce any person to practice abortion) for abortion access globally.

As Congress again considers increased assistance for the global response to COVID-19, we look at how current U.S. global COVID-19 emergency funding is being channeled, particularly to countries and regions.

This Vaccine Monitor survey shows the public is largely supportive of the U.S. role in distributing COVID-19 vaccines globally, as well as other response efforts including the distribution of masks and COVID-19 rapid tests.

This primer provides an overview of congressional engagement in global health. It examines the structure of Congress and its role and key activities in global health. It then illustrates these by examining two global health examples: the creation and evolution of PEPFAR and the 2014/2015 Ebola outbreak in West Africa.

This report finds the public is generally supportive of U.S. distribution of vaccines internationally, though more likely to prefer the U.S. playing a major role versus a leading one, and there are partisan differences. The analysis also examines how different information affects the public’s views.

This dashboard monitors progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates. It includes data for 54 countries, including 13 PEPFAR high-burden countries, and tracks progress against 6 different indicators.